‘Highly effective’ ovarian cancer treatment could help thousands of women

A phase 1 trial of a drug combination, VS-6766 and defactinib, was found to shrink tumours in patients with low-grade serous ovarian cancer. Photograph: Science Photo Library/Alamy Stock Photo

A phase 1 trial of a drug combination, VS-6766 and defactinib, was found to shrink tumours in patients with low-grade serous ovarian cancer. Photograph: Science Photo Library/Alamy Stock Photo

source https://www.theguardian.com/society/2021/sep/19/highly-effective-ovarian-cancer-treatment-could-help-thousands-of-women